BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37194408)

  • 1. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
    Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
    J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
    Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
    EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
    Xu Y; Li Q; Lin Z; Lin Y
    Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
    Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
    Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
    Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
    BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
    Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
    J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
    Li Z; Cai J; Zhao Y; Cai J; Zhao X
    J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative diagnosis of solitary pulmonary nodules with a novel hematological index model based on circulating tumor cells.
    Zhou Q; He Q; Peng L; Huang Y; Li K; Liu K; Li D; Zhao J; Sun K; Li A; He W
    Front Oncol; 2023; 13():1150539. PubMed ID: 37207165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
    Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
    Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor analysis of the patients with solitary pulmonary nodules and establishment of a prediction model for the probability of malignancy].
    Wang X; Xu YH; Du ZY; Qian YJ; Xu ZH; Chen R; Shi MH
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):115-120. PubMed ID: 29502371
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
    Yue YS; Sun ZH; Cui Q; Jiang GZ
    Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a prediction model for the probability of malignancy in solid solitary pulmonary nodules in northwest China.
    Duan XQ; Wang XL; Zhang LF; Liu XZ; Zhang WW; Liu YH; Dong CH; Zhao XH; Chen L
    J Surg Oncol; 2021 Mar; 123(4):1134-1143. PubMed ID: 33497476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
    Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.